布地奈德鼻腔冲洗在未手术慢性鼻窦炎伴鼻息肉患者中的随机双盲安慰剂对照研究
本研究为随机双盲安慰剂对照平行组试验,纳入52例未接受过鼻窦手术的弥漫型2型慢性鼻窦炎伴鼻息肉患者,比较每日两次1 mg布地奈德与生理盐水鼻腔冲洗4周的效果。意向性分析显示布地奈德组在SNOT-22、VAS和NPS上改善显著优于对照组,CCCRC嗅觉测试无显著差异。结论提示布地奈德鼻腔冲洗可能有助于控制未手术或等待手术患者的鼻窦症状。
要点
- 布地奈德鼻腔冲洗4周可显著改善未手术CRSwNP患者的SNOT-22、VAS和NPS。
- CCCRC嗅觉测试在两组间无显著差异。
- 布地奈德鼻腔冲洗或可用于不宜手术或等待手术的CRSwNP患者。
核心结论
- 布地奈德鼻腔冲洗可能成为控制未手术CRSwNP患者鼻窦症状的重要工具。
研究设计与样本
- 随机、双盲、安慰剂对照平行组研究,纳入52例无既往鼻窦手术的弥漫型2型CRSwNP患者。
- 患者随机接受1 mg布地奈德或生理盐水鼻腔冲洗,每日两次,持续四周。
主要发现
- 意向性分析显示布地奈德组SNOT-22改善显著优于对照组,平均差异18.1分(95% CI: 3.4至32.8;p=0.017)。
- 布地奈德组VAS改善显著优于对照组,平均差异2.24分(95% CI: 0.35至4.13;p=0.018)。
- 布地奈德组NPS改善显著优于对照组,平均差异0.73分(95% CI: 0.25至1.21;p=0.003)。
- CCCRC嗅觉测试两组间无显著差异。
关键数值与推荐
- 主要结局为SNOT-22变化;次要结局包括VAS、NPS和CCCRC嗅觉测试。
- 布地奈德鼻腔冲洗用法为1 mg每日两次,持续四周。
临床怎么用
- 对于不宜手术或等待手术的CRSwNP患者,可考虑布地奈德鼻腔冲洗以控制鼻窦症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The indication for nasal irrigation with corticosteroids after sinus surgery in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is well established, as surgery facilitates distribution throughout the sinonasal cavity. However, it remains unknown whether this approach could also provide therapeutic benefit prior to surgery. This study aims to compare the effect of budesonide versus saline nasal irrigation in surgically naive CRSwNP patients. METHODS: A randomized, double-blind, placebo-controlled parallel-group study was conducted in 52 patients with diffuse type 2 CRSwNP with no previous sinus surgery. Patients were randomized to receive either 1 mg budesonide or saline nasal irrigation twice daily for four weeks. The primary outcome was the change in the 22-item Sinonasal Outcome Test (SNOT-22). Secondary outcomes included the Visual Analogue Scale (VAS), Nasal Polyp Score (NPS), and the Connecticut (CCCRC) olfactory test. RESULTS: A total of 52 patients were randomized (mean age 50.1 ± 12.9 years; 51.9% female). The intention-to-treat (ITT) analysis showed that the budesonide nasal irrigation group demonstrated a significantly greater improvement in SNOT-22 (mean difference: 18.1 points [95% CI: 3.4 to 32.8; p = 0.017]), VAS (mean difference 2.24 points [95% CI: 0.35 to 4.13; p = 0.018]) and NPS (mean difference: 0.73 points [95% CI: 0.25 to 1.21]; p = 0.003). No significant differences were observed between groups in CCCRC. CONCLUSION: Budesonide nasal irrigation may be an important tool for controlling sinonasal symptoms in patients with CRSwNP who are not candidates for sinus surgery or while awaiting surgical treatment.
引用
- Sant'Ana J, Pontes I, Floriano C, et al. Effect of Budesonide Nasal Irrigation in Patients With Chronic Rhinosinusitis With Nasal Polyps Without Prior Sinus Surgery: A Randomized, Double-Blind, Placebo-Controlled Study. Int Forum Allergy Rhinol. 2026. PMID: 41686524. doi:10.1002/alr.70112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。